References
Cohen JI, Brunell PA, Straus SE, Krause PR (1999) Recent advances in varicella-zoster virus infection. Ann Intern Med 130(11):922–932
Buchbinder SP, Katz MH, Hessol NA, Liu JY, O’Malley PM, Underwood R, Holmberg SD (1992) Herpes zoster and human immunodeficiency virus infection. J Infect Dis 166(5):1153–1156
Hata A, Kuniyoshi M, Ohkusa Y (2011) Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection 39(6):537–544
Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342(9):635–645
Rusthoven JJ, Ahlgren P, Elhakim T, Pinfold P, Reid J, Stewart L, Feld R (1988) Varicella-zoster infection in adult cancer patients. A population study. Arch Intern Med 148(7):1561–1566
Habel LA, Ray GT, Silverberg MJ, Horberg MA, Yawn BP, Castillo AL et al (2012) The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomark Prev 22(1):82–90
Calabria F, Zappini F, Vattemi G, Tinazzi M (2014) Pearls & Oy-sters: an unusual case of varicella-zoster virus cerebellitis and vasculopathy. Neurology 82(2):e14–e15
Mpaka M, Karantanas AH, Zakynthinos E (2008) Atypical presentation of varicella-zoster virus encephalitis in an immunocompetent adult. Heart Lung 37(1):61–66
De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP (2011) Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 18(8):808–819
Konig C, Kleber M, Reinhardt H, Knop S, Wasch R, Engelhardt M (2013) Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients. Ann Hematol 93(3):479–484
Tattevin P, Schortgen F, de Broucker T, Dautheville S, Wolff M (2001) Varicella-zoster virus limbic encephalitis in an immunocompromised patient. Scand J Infect Dis 33(10):786–788
Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E (2013) Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis 17(7):e529–e534
Masci G, Magagnoli M, Gullo G, Morenghi E, Garassino I, Simonelli M, Santoro A (2006) Herpes infections in breast cancer patients treated with adjuvant chemotherapy. Oncology 71(3–4):164–167
König J, Müller F, Fromm MF (2013) Transporters and drug–drug interactions: important determinants of drug disposition and effects. Pharmacol Rev 65(3):944–966
Lee CA, O’Connor MA, Ritchie TK, Galetin A, Cook JA, Ragueneau-Majlessi I et al (2015) Breast Cancer Resistance Protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug–drug interaction study design. Drug Metab Dispos 43:490–509
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
No conflict of interest to declare.
Ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Rodenburg, E.M., Vermeij, F.H., van den Bent, M.J. et al. Varicella zoster virus encephalitis in a patient with a solid carcinoma: a case report. J Neurol 264, 1281–1283 (2017). https://doi.org/10.1007/s00415-017-8466-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-017-8466-3